Calretinin: A Selective Marker of Normal and Neoplastic Mesothelial Cells in Serous Effusions

Acta Cytologica

Volumn 41, Issue 6, 1997, Pages 1757-1761

  Barberis, Massimo C P ^a,b,c,d   Faleri, Maurizio ^a,b,c   Veronese, Silvio ^a,b,c   Casadio, Chiara ^a,b,c,e   Viale, Giuseppe ^a,b,c,e  

^a Paderno Dugnano   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d Emilio Bernardelli Foundation   (Italy)

^e EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Calretinin; Epithelial; Markers; Neoplasms; Tumor

Indexed keywords

CALRETININ;

ARTICLE; CELL SUSPENSION; CYTOLOGY; DIAGNOSTIC VALUE; DRUG RECEPTOR BINDING; EFFUSION; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MALIGNANT NEOPLASTIC DISEASE; MESOTHELIOMA; MESOTHELIUM CELL; PRIORITY JOURNAL;

EID: 0030696701     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000333181     Document Type: Article

References (27)

1. Amin KM, Litzky LA, Smythe WR, Mooney AM, Mews DJY, Pass HI, Kari C, Rodeck U, Rauscher FJ III, Kaiser LR, Albeda SM: Wilms' tumor susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma. Am J Pathol 1995;146:344-356
2. Bedrossian CW, Bonsib S, Moran C: Differential diagnosis between mesothelioma and adenocarcinoma: A multimodal approach based on ultrastructure and immunocytochem-istry. Semin Diagn Pathol 1992;9:124-140
3. Brown RW, Clark GM, Tandon AK, Allred DC: Multiple marker-immuncytochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. Hum Pathol 1993;24:347-354
4. Carafoli E: Intracellular calcium homeostasis. Ann Rev Biochem 1987;56:395-433
5. Chang K, Pai LH, Pass H, Pogrebniak HW, Tsao MS, Pastan I, Willingham MC: Monoclonal antibody K1 reacts with epithelial mesothelioma but not with lung adenocarcinoma. Am J Surg Pathol 1992;16:259-268
6. Clark SP, Chou ST, Martin TJ, Danks JA: Parathyroid hormone-related protein antigen localization distinguishes between mesothelioma and adenocarcinoma of the lung. J Pathol 1995;176:161-165
7. Collins CL, Ordonez NG, Schaefer R, Cook CD, Xie S-S, Granger J, Hsu P-L, Fink L, Hsu S-M: Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma. Am J Pathol 1992;141:827-833
8. Cordell JL, Falini B, Erber WN: Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984;32: 219-220
9. Delahaye M, Hoogsteden HC, Van der Kwast TH: Immuno-cytochemistry of malignant mesothelioma: OV632 as a marker of malignant mesothelioma. J Pathol 1991;165: 137-143
10. Doglioni C, Dei Tos AP, Laurino L, Iuzzolino P, Chiarelli C, Celio MR, Viale G: Calretinin: A novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 1996;20: 1037-1046
11. Donna A, Betta PG, Bellingeri D, Marchesini A: New maker for mesothelioma: An immunoperoxidase study. J Clin Pathol 1986;39:961-968
12. Donna A, Betta GP, Bellingeri D, Tallarida F, Pavesi M, Pas-tormerlo M: Cytologic diagnosis of malignant mesothelioma in serous effusions using antimesothelial-cell antibody. Diagn Cytopathol 1992;8:361-365
13. Frisman DM, McCarthy WF, Schleiff P, Buckner SB, Nocito JD Jr, O'Leary TJ: Immunocytochemistry in the differential diagnosis of effusions: Use of logistic regression to select a panel of antibodies to distinguish adenocarcinomas from mesothelial proliferations. Mod Pathol 1993;6: 179-184
14. Gotzos V, Schwaller B, Hetzel N, Tsustos Castilio M, Celio MR: Expression of the calcium binding protein calretinin in WiDr cells and its correlation to their cell cycle. Exp Cell Res 1992;202:292-302
15. Gotzos V, Vogt P, Celio MR: The calcium binding protein Calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type. Pathol Res Pract 1996; 192:137-147
16. Kiraly E, Gotzos V, Celio MR: In vitro detection of calretinin immunoreactivity in chicken embryo dorsal root ganglion neurons: A possible developmental marker. Dev Brain Res 1993;76:260-263
17. Kortsik CS, Werner P, Freudenberg N, Virchow JC Jr, Kroegel C, Pott M, Matthys H: Immunocytochemical characterization of malignant mesothelioma and carcinoma metastatic to the pleura: IOB3: A new tumor marker. Lung 1995;173:79-87
18. Luth HJ, Winkelmann E, Celio MR: Light-end electron microscopic localization of parvalbumin, calbinding-D28k and calretinin in the dorsal lateral geniculate nucleus of the rat. J Hirnforsch 1993;34:47-56
19. Miettinen M, Kowatich AJ: HMBE-1: A monoclonal antibody useful in the differential diagnosis of mesothelioma, adenocarcinoma and soft-tissue and bone tumors Appl Immuno-histochem 1995;3:115-122
20. Motoyama T, Watanabe T, Okazaki E, Tanaka N, Watanabe H: Immunohistochemical properties of malignant mesothelioma cells in histologic and cytologic specimens. Acta Cytol 1995;39:164-170
21. Pohl V, Van Rampelbergh J, Mellaert S, Parmentier M, Pochet R: Calretinin in rat ovary: An in situ hybridization and immunohistochemical study. Biochim Byophis Acta 1992;1160:87-94
22. Resibois A, Rogers JH: Calretinin in rat brain: an immuno-histochemical study. Neuroscience 1992;46:101-134
23. Ruitenbeek T, Gouw AS, Poppema S: Immunocytology of body cavity fluids: MOC-31, a monoclonal antibody discriminating between mesothelial and epithelial cells. Arch Pathol Lab Med 1994;118:265-269
24. Stoop JA, Hendriks JG, Berends D: Identification of malignant cells in serous effusions using a panel of monoclonal antibodies Ber-EP4, MCA-b-12, and EMA. Cytopathology 1992; 3:297-302
25. Strauss IK, Isaacs KR, Ha QN, Jacobowitz DM: Calretinin is expressed in the leydig cells of rat testis. Biochim Biophys Acta 1994;1219:435-440
26. Winski L, Nakata H, Martin BM, Jacobowitz DM: Isolation, partial amino acid sequence and immunohistochemical localization of a brain specific calcium binding protein. Proc Natl Acad Sci USA 1989;86:10139-10143
27. Yamada T, Jiping J, Endo R, Gotoh M, Shimosato Y, Hiro-hashi S: Molecular cloning of a cell-surface glycoprotein that can potentially discriminate mesothelium from epithelium: Its identification as vascular cell adhesion molecule 1. Br J Cancer 1995;71:562-570